Trial Profile
A randomised study to evaluate the safety and efficacy of prolonged adjuvant capecitabine chemotherapy on survival of gastric cancer patients after D2 gastrectomy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Apr 2016
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 04 Apr 2016 New trial record